Buy & Sell C3.ai Inc (AI) – C3.ai Inc Price Today
Aura AI Summary
Key Stats
- $1.39BMarket Cap
- TechnologySector
- -33.33%3M Drawdown
- $778.25MEnterprise Value
- -Dividend Yield
- 5% Buy | 95% SellTrading Activity
- 125 daysTypical Hold Time
C3.ai Inc (AI) is currently valued at a market capitalization of $1.39B, with an enterprise value of $778.25M. Over the past 52 weeks, C3.ai Inc has traded between a low of $7.76 and a high of $29.16, highlighting its annual price range. Over the past three months, C3.ai Inc has recorded a drawdown of -33.33%, reflecting recent price volatility. On average, investors hold C3.ai Inc for approximately 125 days, indicating typical investor behavior on the platform.
About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Most Recent News
Tarsus Pharmaceuticals to present at three investor conferences in May 2026
Tarsus Pharmaceuticals announced its management will participate in three upcoming investor conferences in May 2026: Bank of America Securities Health Care Conference on May 12, H.C. Wainwright BioConnect Investor Conference on May 19, and Stifel Vir...
Oil prices drop below $100 while gasoline prices hit highest since 2022, boosting refiners' profits.
Crude oil prices fell below $96 a barrel amid ceasefire talks, but gasoline prices rose to $4.56 per gallon, the highest since summer 2022. This divergence is driving refining profit margins, measured by the 3-2-1 crack spread, to a near-record $56.2...
Acumen Pharmaceuticals to present at Bank of America 2026 Health Care Conference on May 14.
Acumen Pharmaceuticals, a clinical-stage biotech company focused on Alzheimer's disease treatments, will participate in a fireside chat at the Bank of America Securities 2026 Health Care Conference on May 14, 2026. The company is advancing its lead d...